Evidence map›Paper›PMID 33311878›Full record

ArticleIndian journal of palliative care

Impact of Radiation Therapy on Pain Relief of Cancer Patients Affected by on Malignant Psoas Syndrome: 26 Years of Experience.

Alexandros Gerontopoulos, Eftychia Mosa, Filippo Alongi, Ioannis Kokakis, Haytham Hamed Saraireh, Nikolaos Tsoukalas, Nikolaos Charalampakis, Konstantinos Tsanadis, Konstantinos Tsapakidis, Maragkouli Eleni and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Indian journal of palliative care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Alexandros GerontopoulosFaculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, 41500, Larisa, Greece.
Eftychia MosaDepartment of Radiation Oncology, General Anti-Cancer Hospital Saint Savvas, 171 Alexandras Avenue, 115 22, Athens, Greece.
Filippo AlongiDepartment of Radiation Oncology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Ioannis KokakisFirst Department of Radiology, Radiotherapy Unit, Aretaieion University Hospital, Medical School of Athens, Athens, Greece.
Haytham Hamed SarairehDepartment of Radiation Oncology, Jordanian Royal Medical Services, King Hussein Medical Center, King Abdullah II St 230, Amman, Jordan.
Nikolaos TsoukalasDepartment of Oncology, Veterans Hospital (NIMTS), 10-12 Monis Petraki Str, 115 21, Athens, Greece.
Nikolaos CharalampakisOncology Clinic, H. Dunant Hospital, 107 Mesogeion Av, Athens, Greece.
Konstantinos TsanadisDepartment of Radiation Oncology, University Hospital of Larissa, Biopolis, 41500, Larisa, Greece.
Konstantinos TsapakidisDepartment of Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, 41500, Larisa, Greece.
Maragkouli EleniDepartment of Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, 41500, Larisa, Greece.
Christos ChristopoulosDepartment of Radiation Oncology, Groupe Hospitalier Intercommunal Le Raincy, Montfermeil, 10 Rue du Général Leclerc, 93370 Montfermeil, France.
Maria ToliaFaculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, 41500, Larisa, Greece.
University of Thessaly · GRAretaeio Hospital · GROspedale Sacro Cuore Don Calabria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe malignant psoas syndrome (MPS) is a rare and complex cancer-related clinical entity, with a significant impact on cancer patients' quality of life. The literature describing malignant infiltration of the psoas muscle as well as its management is limited. The primary endpoint of the study was the assessment of pain relief in symptomatic terminal-stage MPS patients. MATERIALS AND

methodsPatients underwent hypofractionated (two- or three-dimensional conformal) radiotherapy as palliative treatment. A dose of 42.5 Gy in 17 daily fractions (2.5 Gy/fraction) was prescribed. Pain response was measured before 3 and 6 months after radiation delivery.

resultsBetween May 1992 and April 2019, eight patients were treated. The median age was 75 years (range: 59-87 years). All patients had distant metastatic disease at the time of treatment. We found a significant pain relief (median duration of response of 105 days) and an improvement in health-related quality of life.

conclusionsRadiotherapy had a favorable outcome and can be considered an effective analgesic treatment in case of painful MPS.

Indexed as

Malignant psoas syndromepainradiotherapy

Identifiers

PMID33311878
PMCPMC7725172
OpenAlexW3082703108

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.